Caliway Biopharmaceuticals Co., Ltd.
Caliway Biopharmaceuticals Co., Ltd.
Explore linked clinical trials.5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat | Subcutaneous Fat | Recruiting | Phase 3 | 2026-09-22 | NCT07140939 | |
| A Study to Evaluate the Maintenance of Efficacy and Long-term Safety of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1) | Subcutaneous Fat | Not yet recruiting | Phase 3 | 2026-07-30 | NCT07733947 | |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat | Subcutaneous Fat | Recruiting | Phase 2 | 2026-06-04 | NCT07608770 | |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat | Subcutaneous Fat | Not yet recruiting | Phase 2 | 2026-05-29 | NCT07608757 | |
| A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 ) | Subcutaneous Fat | Not yet recruiting | Phase 3 | 2026-04-14 | NCT07526974 |